BIT/ARBS (BIT/ARBS)

Borsa Italiana: BIT/ARBS · EUR

€3.00

-0.04 (-1.3%)· Recorded snapshot

Market cap	20M
Revenue (ttm)	4.7M
Net income (ttm)	2M
EPS (ttm)	€0.30
Shares out	6.7M
P/E (trailing)	10.0x
Dividend	€0.13 (4.21%)
Volume	3,750
Beta	0.64

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 4.7M
Net income (ttm): 2M
EPS (ttm): €0.30
P/E (trailing): 10.0x
Market cap: 20M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-09-13 02:00 UTC

Forward P/En/a

P25 13.1P50 16.7P75 18.7

Trailing P/E10

P25 13.3P50 22.1P75 25.9

ROE16.7

P25 -0.7P50 7.9P75 12.7

ROIC19.4

P25 5.5P50 8.6P75 18.4

Benchmarks · 1M

S&P 500-0.9%

Nasdaq Composite-0.4%

Dow Jones Industrial Average-2.3%

Russell 2000-4.1%

All BIT/ARBS indicators

Market & fundamental data

Available fields

222

Groups with data

Currency

EUR

Showing 222 of 222 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Italy
Country code	IT
Employees	36
Employees Change	2%
Employees Change Percent	5.88
Enterprise value	EUR 18.9M
Exchange	Borsa Italiana
Financial currency	EUR
First seen	2026-05-10
Industry	Biotechnology
Isin	IT0005386369
Last refreshed	2026-09-13
Market cap	EUR 20M
Price	EUR 3
Price currency	EUR
Sector	Healthcare
Sector PE	20.14
Sector PE Fwd	16.21
Sic	2836
Symbol	bit/ARBS
Website	https://www.arterrabio.it

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	10.04%
EV Earnings	9.42x
EV/EBIT	9.78x
EV/EBITDA	8.5x
EV/FCF	12.28x
EV/Sales	4.02x
FCF yield	7.7%
P/B ratio	1.59x
P/E ratio	9.96x
P/S ratio	4.25x
PE Ratio3 Y	10.93x
PE Ratio5 Y	14.84x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	41.06%
EBITDA Margin	47.22%
FCF margin	32.71%
Gross margin	62.44%
Gross Profit	EUR 2.9M
Gross Profit Growth	51.5%
Gross Profit Growth Q	62.43%
Gross Profit Growth3 Y	-6.68%
Gross Profit Growth5 Y	2.66%
Net Income	EUR 2M
Net Income Growth	65.74%
Net Income Growth Q	-0.98%
Net Income Growth Qo Q	0%
Net Income Growth Quarters	3%
Net Income Growth Years	2%
Net Income Growth3 Y	16.94%
Net Income Growth5 Y	22.91%
Pretax Margin	42.46%
Profit Margin	42.64%
Profitable Quarters	EUR 18
Profitable Years	9
ROA	8.63
Roa5y	7.18
ROCE	14.1
ROE	16.72
Roe5y	13.14
ROIC	19.38
Roic5y	18.81

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	25.16%
Cagr3y	22.09%
Cagr5y	0.25%
Div CAGR3	14.47%
EPS Growth Q	-0.98
EPS Growth Qo Q	0
EPS Growth Quarters	3
EPS Growth Years	2
EPS Growth5 Y	22.6
FCF Growth	77.3%
OCF Growth	98.13%
OCF Growth Q	26.97%
OCF Growth Qo Q	0%
Revenue Growth	34.8x
Revenue Growth Q	48.77x
Revenue Growth Qo Q	0x
Revenue Growth Quarters	4x
Revenue Growth Years	2x
Revenue Growth3 Y	-1.31x
Revenue Growth5 Y	4.78x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.34
Assets	EUR 14.6M
Cash	EUR 1.3M
Current Assets	EUR 8.3M
Current Liabilities	EUR 824,098
Debt	EUR 260,351
Debt EBITDA	EUR 0.12
Debt Equity	EUR 0.02
Debt FCF	EUR 0.17
Equity	EUR 12.6M
Interest Coverage	2,178.1
Liabilities	EUR 2M
Long Term Assets	EUR 6.3M
Long Term Liabilities	EUR 1.2M
Net Cash	EUR 1.1M
Net Cash By Market Cap	EUR 5.42
Net Cash Growth	-9.48%
Net Debt EBITDA	EUR -0.49
Net Debt Equity	EUR -0.09
Net Debt FCF	EUR -0.7
Tangible Book Value	EUR 12.6M
Tangible Book Value Per Share	EUR 1.89
WACC	7.69

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	7.8
Inventory Turnover	1.23
Net Working Capital	EUR 4.7M
Quick ratio	6.02
Working Capital	EUR 6M
Working Capital Turnover	EUR 0.65

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	15.38%
Dividend Growth Years	1%
Dividend per share	EUR 0.13
Dividend Years	5
Dividend Yield	4.21%
Ex Div Date	2026-05-04
Last Dividend	EUR 0.15
Payout Frequency	Annual
Payout Ratio	42.2%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	25.14%
200-day SMA	3.01
3Y total return	82.03%
50-day SMA	3.11
50-day SMA vs 200-day SMA	50over200
5Y total return	1.25%
All Time High	5.34
All Time High Change	-43.82%
All Time High Date	2019-11-21
All Time Low	1.48
All Time Low Change	102.7%
All Time Low Date	2023-11-16
ATR	0.04
Beta	0.64
Beta1y	0.52
Beta2y	0.65
Ch YTD	-0.66
High	3.05
High52	3.58
High52 Date	2025-10-09
High52ch	-16.2%
Low	3
Low52	2.52
Low52 Date	2025-09-15
Low52ch	20%
Ma50ch	-3.41%
Price vs 200-day SMA	-0.43%
RSI	40.27
RSI Monthly	58.26
RSI Weekly	49.47
Sharpe ratio	0.67x
Sharpe Ratio3y	0.82x
Sharpe Ratio5y	0.05x
Sortino ratio	1.33
Sortino Ratio3y	1.56
Sortino Ratio5y	0.26
Total Return	4.21%
Tr YTD	4.42
Tr1m	-4.15%
Tr1w	-1.64%
Tr3m	9.09%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,641,256%
Net Borrowing	-96,077
Shares Insiders	30.3%
Shares Out	6,658,493
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	2,287.5x
Bv Per Share	1.89
CAPEX	EUR -453,293
Ch1m	-4.15
Ch1w	-1.64
Ch1y	19.05
Ch3m	9.09
Ch3y	55.44
Ch5y	-18.92
Ch6m	7.14
Change	-1.32%
Change From Open	-1.64
Close	3.04
Days Gap	0.33
Depreciation Amortization	289,787
Dollar Volume	11,250
Earnings Date	2026-09-28
EBIT	EUR 1.9M
EBITDA	EUR 2.2M
EPS	EUR 0.3
F Score	6
FCF	EUR 1.5M
FCF EV Yield	8.15x
FCF Per Share	EUR 0.23
Financing CF	-942,777
Fiscal Year End	December
Founded	2,003
Graham Number	3.57924
Graham Upside	19.31
Income Tax	EUR -8,495
Investing CF	-3,050,081
Is Primary Listing	1
Last Earnings Date	2025-12-23
Last Report Date	2024-12-31
Lynch Fair Value	EUR 6.9
Lynch Upside	130.1
Ma150	2.98
Ma150ch	0.84%
Ma20	3.06
Ma20ch	-1.86%
Net CF	-2,000,635
Next Earnings Date	2026-09-28
Open	3.05
P FCF Ratio	12.98
P OCF Ratio	10.03
Payment Date	2026-05-06
Position In Range	0
Ppne	1,508,180
Price Date	2026-09-11
Price EBITDA	EUR 8.99
Ptbv Ratio	1.59
Relative Volume	1.72x
Revenue	4,704,697x
Tax By Revenue	-0.18x
Tr6m	12.63%
Volume	3,750
Z Score	7

Deeper analysis on BIT/ARBS

14 sections in the full report · jump straight to what you need

Forecast

Bull, base, and bear cases with expected-return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Six-factor overlay and 9-category weighted scorecard.

→

Recommendation

Final action, action steps, opportunity, and biggest risk.

→

Perspectives

Growth, value, and income investor reads.

→

Frequently asked questions

About this BIT/ARBS report

Is a complete BIT/ARBS research report available?

No complete published report is available for bit/ARBS (BIT/ARBS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BIT/ARBS (BIT/ARBS)

Borsa Italiana: BIT/ARBS · EUR

€3.00

-0.04 (-1.3%)· Recorded snapshot

Market cap	20M
Revenue (ttm)	4.7M
Net income (ttm)	2M
EPS (ttm)	€0.30
Shares out	6.7M
P/E (trailing)	10.0x
Dividend	€0.13 (4.21%)
Volume	3,750
Beta	0.64

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 4.7M
Net income (ttm): 2M
EPS (ttm): €0.30
P/E (trailing): 10.0x
Market cap: 20M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-09-13 02:00 UTC

Forward P/En/a

P25 13.1P50 16.7P75 18.7

Trailing P/E10

P25 13.3P50 22.1P75 25.9

ROE16.7

P25 -0.7P50 7.9P75 12.7

ROIC19.4

P25 5.5P50 8.6P75 18.4

Benchmarks · 1M

S&P 500-0.9%

Nasdaq Composite-0.4%

Dow Jones Industrial Average-2.3%

Russell 2000-4.1%

All BIT/ARBS indicators

Market & fundamental data

Available fields

222

Groups with data

Currency

EUR

Showing 222 of 222 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Italy
Country code	IT
Employees	36
Employees Change	2%
Employees Change Percent	5.88
Enterprise value	EUR 18.9M
Exchange	Borsa Italiana
Financial currency	EUR
First seen	2026-05-10
Industry	Biotechnology
Isin	IT0005386369
Last refreshed	2026-09-13
Market cap	EUR 20M
Price	EUR 3
Price currency	EUR
Sector	Healthcare
Sector PE	20.14
Sector PE Fwd	16.21
Sic	2836
Symbol	bit/ARBS
Website	https://www.arterrabio.it

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	10.04%
EV Earnings	9.42x
EV/EBIT	9.78x
EV/EBITDA	8.5x
EV/FCF	12.28x
EV/Sales	4.02x
FCF yield	7.7%
P/B ratio	1.59x
P/E ratio	9.96x
P/S ratio	4.25x
PE Ratio3 Y	10.93x
PE Ratio5 Y	14.84x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	41.06%
EBITDA Margin	47.22%
FCF margin	32.71%
Gross margin	62.44%
Gross Profit	EUR 2.9M
Gross Profit Growth	51.5%
Gross Profit Growth Q	62.43%
Gross Profit Growth3 Y	-6.68%
Gross Profit Growth5 Y	2.66%
Net Income	EUR 2M
Net Income Growth	65.74%
Net Income Growth Q	-0.98%
Net Income Growth Qo Q	0%
Net Income Growth Quarters	3%
Net Income Growth Years	2%
Net Income Growth3 Y	16.94%
Net Income Growth5 Y	22.91%
Pretax Margin	42.46%
Profit Margin	42.64%
Profitable Quarters	EUR 18
Profitable Years	9
ROA	8.63
Roa5y	7.18
ROCE	14.1
ROE	16.72
Roe5y	13.14
ROIC	19.38
Roic5y	18.81

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	25.16%
Cagr3y	22.09%
Cagr5y	0.25%
Div CAGR3	14.47%
EPS Growth Q	-0.98
EPS Growth Qo Q	0
EPS Growth Quarters	3
EPS Growth Years	2
EPS Growth5 Y	22.6
FCF Growth	77.3%
OCF Growth	98.13%
OCF Growth Q	26.97%
OCF Growth Qo Q	0%
Revenue Growth	34.8x
Revenue Growth Q	48.77x
Revenue Growth Qo Q	0x
Revenue Growth Quarters	4x
Revenue Growth Years	2x
Revenue Growth3 Y	-1.31x
Revenue Growth5 Y	4.78x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.34
Assets	EUR 14.6M
Cash	EUR 1.3M
Current Assets	EUR 8.3M
Current Liabilities	EUR 824,098
Debt	EUR 260,351
Debt EBITDA	EUR 0.12
Debt Equity	EUR 0.02
Debt FCF	EUR 0.17
Equity	EUR 12.6M
Interest Coverage	2,178.1
Liabilities	EUR 2M
Long Term Assets	EUR 6.3M
Long Term Liabilities	EUR 1.2M
Net Cash	EUR 1.1M
Net Cash By Market Cap	EUR 5.42
Net Cash Growth	-9.48%
Net Debt EBITDA	EUR -0.49
Net Debt Equity	EUR -0.09
Net Debt FCF	EUR -0.7
Tangible Book Value	EUR 12.6M
Tangible Book Value Per Share	EUR 1.89
WACC	7.69

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	7.8
Inventory Turnover	1.23
Net Working Capital	EUR 4.7M
Quick ratio	6.02
Working Capital	EUR 6M
Working Capital Turnover	EUR 0.65

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	15.38%
Dividend Growth Years	1%
Dividend per share	EUR 0.13
Dividend Years	5
Dividend Yield	4.21%
Ex Div Date	2026-05-04
Last Dividend	EUR 0.15
Payout Frequency	Annual
Payout Ratio	42.2%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	25.14%
200-day SMA	3.01
3Y total return	82.03%
50-day SMA	3.11
50-day SMA vs 200-day SMA	50over200
5Y total return	1.25%
All Time High	5.34
All Time High Change	-43.82%
All Time High Date	2019-11-21
All Time Low	1.48
All Time Low Change	102.7%
All Time Low Date	2023-11-16
ATR	0.04
Beta	0.64
Beta1y	0.52
Beta2y	0.65
Ch YTD	-0.66
High	3.05
High52	3.58
High52 Date	2025-10-09
High52ch	-16.2%
Low	3
Low52	2.52
Low52 Date	2025-09-15
Low52ch	20%
Ma50ch	-3.41%
Price vs 200-day SMA	-0.43%
RSI	40.27
RSI Monthly	58.26
RSI Weekly	49.47
Sharpe ratio	0.67x
Sharpe Ratio3y	0.82x
Sharpe Ratio5y	0.05x
Sortino ratio	1.33
Sortino Ratio3y	1.56
Sortino Ratio5y	0.26
Total Return	4.21%
Tr YTD	4.42
Tr1m	-4.15%
Tr1w	-1.64%
Tr3m	9.09%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,641,256%
Net Borrowing	-96,077
Shares Insiders	30.3%
Shares Out	6,658,493
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	2,287.5x
Bv Per Share	1.89
CAPEX	EUR -453,293
Ch1m	-4.15
Ch1w	-1.64
Ch1y	19.05
Ch3m	9.09
Ch3y	55.44
Ch5y	-18.92
Ch6m	7.14
Change	-1.32%
Change From Open	-1.64
Close	3.04
Days Gap	0.33
Depreciation Amortization	289,787
Dollar Volume	11,250
Earnings Date	2026-09-28
EBIT	EUR 1.9M
EBITDA	EUR 2.2M
EPS	EUR 0.3
F Score	6
FCF	EUR 1.5M
FCF EV Yield	8.15x
FCF Per Share	EUR 0.23
Financing CF	-942,777
Fiscal Year End	December
Founded	2,003
Graham Number	3.57924
Graham Upside	19.31
Income Tax	EUR -8,495
Investing CF	-3,050,081
Is Primary Listing	1
Last Earnings Date	2025-12-23
Last Report Date	2024-12-31
Lynch Fair Value	EUR 6.9
Lynch Upside	130.1
Ma150	2.98
Ma150ch	0.84%
Ma20	3.06
Ma20ch	-1.86%
Net CF	-2,000,635
Next Earnings Date	2026-09-28
Open	3.05
P FCF Ratio	12.98
P OCF Ratio	10.03
Payment Date	2026-05-06
Position In Range	0
Ppne	1,508,180
Price Date	2026-09-11
Price EBITDA	EUR 8.99
Ptbv Ratio	1.59
Relative Volume	1.72x
Revenue	4,704,697x
Tax By Revenue	-0.18x
Tr6m	12.63%
Volume	3,750
Z Score	7

Deeper analysis on BIT/ARBS

14 sections in the full report · jump straight to what you need

Forecast

Bull, base, and bear cases with expected-return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Six-factor overlay and 9-category weighted scorecard.

→

Recommendation

Final action, action steps, opportunity, and biggest risk.

→

Perspectives

Growth, value, and income investor reads.

→

Frequently asked questions

About this BIT/ARBS report

Is a complete BIT/ARBS research report available?

No complete published report is available for bit/ARBS (BIT/ARBS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BIT/ARBS (BIT/ARBS)

Price

Financial snapshot

Fair-value bridge

Latest news · BIT/ARBS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BIT/ARBS indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on BIT/ARBS

Frequently asked questions

BIT/ARBS (BIT/ARBS)

Price

Financial snapshot

Fair-value bridge

Latest news · BIT/ARBS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BIT/ARBS indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on BIT/ARBS

Frequently asked questions